BackNabriva Therapeutics Plc Overview

Nabriva Therapeutics Plc Net Income

Profitability analysis for NBRV.

Quarterly Net Income

-$9.12M
22.84% YoY

As of Mar 2023

Annual Net Income (TTM)

-$54.48M
15.22% YoY

Trailing 12 months ending Mar 2023

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...